Windward Prices IPO and Sanofi Placement

Company Windward Bio; Sanofi (affiliate) Event Type IPO pricing and concurrent private placement Modality Monoclonal antibody (long-acting) Asset WIN378 Target TSLP Disease Area Asthma; respiratory and dermatologic disease Summary Windward Bio priced 10,294,117 IPO shares at $17, implying about $175 million in IPO gross proceeds,…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *